Take a look at this month’s featured report and get exciting trading ideas.
April 23, 2015
“Nearly all men can stand adversity, but if you want to test a man’s character, give him power.”
— Abraham Lincoln
Advaxis (ADXS) long is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm-LLO platform technology. The Lm-LLO technology, using bioengineered live attenuated Listeria monocytogenes bacteria, is the only known cancer immunotherapy agent shown in preclinical studies to both generate cancer fighting T-cells directed against a cancer antigen and neutralize Tregs and myeloid-derived suppressor cells MDSCs), that protect the tumor…